Temple Rock Holdings Inc.

CYNAPSUS THERAPEUTICS REPORTS RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2010
TORONTO, ONTARIO--(Marketwire - Nov. 11, 2010) - Cynapsus Therapeutics Inc. ("Cynapsus") (formerly Cannasat Therapeutics Inc.) (TSX VENTURE:CTH), a specialty clinical developmental pharmaceutical company targeting CNS diseases, today announced its results for the nine months ended September 30, 2010. MORE>>